Clinical Trials on Attention-Deficit Hyperactivity Disorder (ADHD) in Austria
Total 72 results
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedAdult Attention-deficit Hyperactivity Disorder (ADHD)Australia
-
Targacept Inc.Completed
-
ShireCompleted
-
Alcobra Ltd.CompletedADHD | Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive TypeUnited States, Israel
-
Alcobra Ltd.TerminatedAttention Deficit Hyperactivity Disorder (ADHD)United States, Israel
-
ShireCompletedADHD Specifically With Executive Function ImpairmentUnited States
-
University of Texas at AustinRecruitingAttention Deficit Hyperactivity Disorder | Cognitive Deficit | Wellness | Attention Difficulties | Attention DeficitUnited States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
AbbottCompletedADHD | Attention-Deficit/Hyperactivity DisorderUnited States
-
Supernus Pharmaceuticals, Inc.CompletedAttention-Deficit/Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)Spain, Germany, Ukraine, France, Italy, Austria, Belgium, Ireland, Netherlands, Poland, Romania, Sweden, United Kingdom
-
Theravance BiopharmaCompletedADHD | Attention-Deficit/Hyperactivity DisorderUnited States
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
Medical University of ViennaCompletedAttention Deficit Hyperactivity DisorderAustria
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity Disorder | Oppositional Defiant DisorderAustralia, Belgium, Denmark, Finland, Germany, Netherlands, Spain, United Kingdom
-
Supernus Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity Disorder (ADHD)United States
-
BRC Operations Pty. Ltd.UnknownAttention Deficit/Hyperactivity DisorderUnited States, Australia, Netherlands
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderAustralia, United Kingdom, Mexico
-
New River PharmaceuticalsShireCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
-
New River PharmaceuticalsCompletedAttention Deficit Hyperactivity Disorder | Attention Deficit Disorders With Hyperactivity | Attention Deficit Hyperactivity DisordersUnited States
-
ShireCompletedAttention-deficit/Hyperactivity DisorderUnited States
-
Targacept Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
ShireCompletedAttention-deficit/Hyperactivity DisorderSpain, Belgium, United States, Netherlands, United Kingdom, Italy, Germany, Canada, France, Sweden
-
SunovionCompleted
-
Noven TherapeuticsCompletedAttention Deficit Hyperactivity DisorderUnited States
-
ShireCompletedAttention Deficit Hyperactivity DisorderSpain, United States, Germany, Poland, Italy, Ukraine, Romania, United Kingdom, Sweden, Austria, Canada, France, Ireland
-
H. Lundbeck A/SCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderSpain, France, Austria, Germany, Belgium, Finland, Italy, Netherlands, Portugal, Sweden, Switzerland, United Kingdom
-
AbbVie (prior sponsor, Abbott)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
ShireTakeda Development Center Americas, Inc.RecruitingAttention Deficit Hyperactivity DisorderSpain, United States, United Kingdom, Belgium, Germany, Netherlands, Portugal, Austria, Sweden
-
Arbor Pharmaceuticals, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
AbbVie (prior sponsor, Abbott)CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
AbbottTerminatedAttention-Deficit/Hyperactivity DisorderUnited States
-
Supernus Pharmaceuticals, Inc.CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
SunovionCompleted
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States, Canada
-
SunovionCompleted
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States, Poland, Spain, Canada, Hungary, Belgium, Germany, Italy, Sweden, United Kingdom
-
Supernus Pharmaceuticals, Inc.TerminatedAttention Deficit Hyperactivity DisorderUnited States
-
FH Joanneum Gesellschaft mbHAustrian Research Promotion AgencyRecruiting
-
Bayside HealthThe AlfredCompletedMental Disorders | Psychotic Disorders | Anxiety Disorders | Attention Deficit and Disruptive Behavior Disorders | Affective DisordersAustralia